IPF Ofev denied as non-formulary by Cigna?

Cigna's specific coverage criteria for ipf ofev are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Deny Ofev (nintedanib) for IPF as Non-Formulary

Cigna's formulary tiers are negotiated annually, and specialty drugs for rare conditions such as idiopathic pulmonary fibrosis are sometimes placed on a non-preferred or excluded tier, or require a formulary exception request before coverage activates. A non-formulary denial does not mean the drug is not covered under any circumstances — it means the standard claims path did not find it on the approved tier list, and a separate exception or prior-authorization process must be completed before the pharmacy claim can be adjudicated.

## Why This Denial Is Appealable

Cigna is required by ACA regulations and most state insurance laws to maintain a formulary exception process. For IPF — a serious, progressive disease with a narrow set of FDA-approved treatments — the exception pathway is well-established and frequently granted when the prescriber documents that the requested drug is medically necessary and that covered alternatives are clinically inappropriate for this patient. There is no therapeutic equivalent that can simply be substituted without medical justification.

## Federal Appeal Framework

• Formulary exception request: This is usually the first step and is distinct from a formal grievance appeal. Submit it with a prescriber letter explaining medical necessity and the inadequacy of formulary alternatives.
• Internal appeal: If the exception is denied, a formal internal appeal follows. Cigna must decide within 30 days (non-urgent) or 72 hours (expedited).
• External review (ACA §2719): Available after adverse internal decision. An independent organization reviews whether the non-formulary placement and exception denial are consistent with your clinical needs. The window is generally up to four months from the denial notice.
• ERISA §503: Employer plans are subject to full-and-fair review; you may obtain all documents Cigna used and submit rebuttal evidence.

## Documentation to Gather

1. Diagnosis confirmation — IPF diagnosis from a pulmonologist or specialist, with supporting HRCT and pulmonary function test documentation. 2. Medical-necessity letter — Prescriber explains why Ofev is the appropriate choice, why any formulary-listed alternative is clinically unsuitable for this patient, and references alignment with the applicable professional guideline organization. 3. Prior-treatment history — Documentation of any previously trialed antifibrotic agents, including dates and reasons for discontinuation, if applicable. 4. Current formulary review — Obtain Cigna's current formulary document (available on the Cigna member portal or upon request) and identify any listed alternative that Cigna may require you to address. Your prescriber's letter should address each named alternative specifically. 5. Financial hardship documentation (if applicable) — Some exception pathways consider patient cost burden; include if relevant.

## Criteria-Mapping Structure

Cigna's formulary exception criteria typically require:

• A confirmed diagnosis for which the drug has an FDA-approved indication
• A clinical explanation of why covered formulary alternatives are contraindicated, ineffective, or otherwise inappropriate (per the prescribing label and the applicable guideline organization — reference the organization, not specific numeric cutoffs)
• Prescriber attestation of medical necessity
• Documentation of prior therapy trials where applicable

List each criterion in one column and cite the corresponding chart entry or letter in the next. Attach the prescriber's medical-necessity letter, relevant specialist records, and the prior-treatment summary as a single organized packet.